Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease
Main Authors: | Heejoon Jang, Kwon Wook Joo, Seung Seok Han |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2019-06-01
|
Series: | Kidney Research and Clinical Practice |
Online Access: | https://doi.org/10.23876/j.krcp.18.0156 |
Similar Items
-
The use of globotriaosylsphingosine to detect and monitor Fabry disease
by: Alharbi, Fahad Jazza
Published: (2016) -
Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
by: Takahiro Tsukimura, et al.
Published: (2014-01-01) -
Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.
by: Brandy Young-Gqamana, et al.
Published: (2013-01-01) -
Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
by: Mehdi Namdar, et al.
Published: (2012-01-01) -
Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2021-09-01)